癌症的低氧相关基因的表达特征来源于解剖学上类似的位置使用TCGA数据库分析的TCGA数据库分析
Hye Lim Bae1, Kyeonghun Jeong2, Suna Yang3
1Department of Surgery, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Medicines (Basel, Switzerland)
|January 22, 2024
概括
与缺氧相关的基因分析揭示了女性生殖和肺癌的明显预后生物标志物. 这项研究确定了影响生存的关键基因,有助于了解癌症进展和生物标志物发展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 缺氧是固体癌症中瘤微环境的一个关键特征.
- 瘤的位置会影响癌症的遗传格局和生物行为.
研究的目的:
- 分析不同瘤部位共享的缺氧相关基因.
- 根据低氧相关的基因表达和瘤分组来确定预后生物标志物.
主要方法:
- 利用来自KEGG和Reactome数据库的850个与缺氧相关的基因,跨越9个途径.
- 根据解剖位置将14种瘤类型分为6组.
- 计算了特定群体的遗传风险得分和评估的生存结果.
主要成果:
- 女性生殖和肺癌组的验证风险得分.
- 确定了与预后相关的特定枢纽基因 (例如,CDKN2A,FN1,ITGA5,IL2RB,LEF1用于女性生殖器;ITGB1,LDHA,GLS2用于肺部).
- 功能丰富揭示了不同的途径 (女性生殖器的皮/皮肤;肺部的细胞因子/防御).
结论:
- 这项研究提供了有关低氧驱动的癌症进展机制的见解.
- 确定了潜在的新生物标志物,用于预测特定癌症类型的预后.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


